ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 305329 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 305329; 2) Community: the network communities that were significantly associated with the response to NSC 305329; 3) Molecule: the relationships between components within communities and NSC 305329; 4) MDR: the compounds that were significantly associated with the NSC 305329.

NSC Compound Enrichment Correlation
NSC 701748 Null 0.026296153644827 0.38746067
NSC 707465 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- 0.026296153644827 -0.033101015
NSC 143095 Pyrazofurin 0.0262961536448272 0.41067905
NSC 2805 2,2',5,5'-Tetrahydroxy-4,4'-dimethylbiphenyl 0.0262961536448272 0.06837569
NSC 315844 2(1H)-Pyrimidinone, 1-(2,5-dihydro-5-oxo-2-furanyl)-5-fluoro-4-methoxy- 0.0273071169565314 0.084274768
NSC 31709 Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride 0.0273071169565314 0.057294578
NSC 374028 Camptothecin Derivative 0.0273071169565314 0.33610932
NSC 603831 Acteoside 0.0273071169565314 0.0082086344
NSC 625500 Null 0.0273071169565314 0.24388378
NSC 633016 Null 0.0273071169565314 0.076008799
Total:24  Current:9    [First] [Prev] [Next] [Last]